Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, although anyone watching the developments emanating from Washington, D.C., can be forgiven for feeling a bit weary. So what better way to recover — and prepare for the week ahead — with a few cups of stimulation? Our choice today is, once again, maple bourbon. Feel free to join us or pick up a bottle of water. Meanwhile, here are a few tidbits to help you along. Hope you have a wonderful day, and stay safe. …

The Food and Drug Administration authorized the use of blood plasma from patients who have recovered from Covid-19 as a treatment for the disease, STAT reports. The decision to issue an emergency use authorization, which President Trump’s press secretary heralded ahead of time as a “major therapeutic breakthrough,” likely falls far short of that description — and could generate intense controversy inside the administration and the broader scientific community.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED